Tablet: Tables 7 and 8 include drugs with clinically important drug interactions and interaction with diagnostics when administered concomitantly with PREVACID and instructions for preventing or managing them. (See Tables 7 and 8.)
Consult the labeling of concomitantly used drug to obtain further information about interactions with PPIs.
Click on icon to see table/diagram/image
Click on icon to see table/diagram/image
IV: PREVACID I.V. is metabolized mainly by hepatic drug-metabolizing enzyme CYP2C19 and CYP3A4.
Gastric antisecretory effect of PREVACID I.V. may promote or inhibit absorption of concomitant drugs.
Contraindications for coadministration: (PREVACID I.V. should not be coadministered with the following drug.): See Table 9.
Click on icon to see table/diagram/image
Precautions for coadministration (PREVACID I.V. should be administered with care when coadministered with the following drugs.): See Table 10.
Click on icon to see table/diagram/image